Biologic therapy use among patients with psoriatic disease was associated with a lower risk for malignancy compared with topical therapy use.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback